21 U.S.C. § 114 to 114d–1
Repealed. Pub. L. 107–171, title X, § 10418(a)(8), (9), May 13, 2002, 116 Stat. 508
Repealed. Pub. L. 107–171, title X, § 10418(a)(8), (9), May 13, 2002, 116 Stat. 508
Search
Search by citation or keyword across the current edition within Title 21.
Repealed. Pub. L. 107–171, title X, § 10418(a)(8), (9), May 13, 2002, 116 Stat. 508
Repealed. Pub. L. 107–171, title X, § 10418(a)(8), (9), May 13, 2002, 116 Stat. 508
Repealed. Pub. L. 92–152, § 3, Nov. 5, 1971, 85 Stat. 419
Repealed. Pub. L. 92–152, § 3, Nov. 5, 1971, 85 Stat. 419
Repealed. Pub. L. 107–171, title X, § 10418(a)(10), (11), May 13, 2002, 116 Stat. 508
Repealed. Pub. L. 107–171, title X, § 10418(a)(10), (11), May 13, 2002, 116 Stat. 508
Repealed. Pub. L. 92–255, title I, § 104, Mar. 21, 1972, 86 Stat. 67
Repealed. Pub. L. 92–255, title I, § 104, Mar. 21, 1972, 86 Stat. 67
Repealed. Pub. L. 106–554, § 1(a)(1) [title V, § 517], Dec. 21, 2000, 114 Stat. 2763, 2763A–73
Repealed. Pub. L. 106–554, § 1(a)(1) [title V, § 517], Dec. 21, 2000, 114 Stat. 2763, 2763A–73
Repealed. Pub. L. 106–185, § 2(c)(3), Apr. 25, 2000, 114 Stat. 210
Repealed. Pub. L. 106–185, § 2(c)(3), Apr. 25, 2000, 114 Stat. 210
Repealed. Pub. L. 107–171, title X, § 10418(a)(1), (8), (16), May 13, 2002, 116 Stat. 507, 508
Repealed. Pub. L. 107–171, title X, § 10418(a)(1), (8), (16), May 13, 2002, 116 Stat. 507, 508
Inapplicability of drug fees to designated medical gases
Inapplicability of drug fees to designated medical gases
Standards for regenerative medicine and regenerative advanced therapies
Standards for regenerative medicine and regenerative advanced therapies
Accelerated approval of priority countermeasures
Accelerated approval of priority countermeasures
Expanded access policy required for investigational drugs
Expanded access policy required for investigational drugs
Use of clinical investigation data from outside the United States
Use of clinical investigation data from outside the United States
Patient participation in medical product discussion
Patient participation in medical product discussion